To better understand the significance of variations of EHD2 expression in breast cancers, we selected the Hs578T, MDA-MB-231 and MDA-MB-436 TNBC cell lines that respectively express three representative levels of EHD2 transcripts i.e. high, medium, and low (Fig. 2a). Here, EHD2 is linked to breast carcinoma.